Understanding the complex mechanisms that govern the fate decisions of human embryonic stem 21 cells (hESCs) is fundamental to their use in cell replacement therapies. The progress of dissecting 22 these mechanisms will be facilitated by the availability of robust high-throughput screening 23 assays on hESCs. In this study, we report an image-based high-content assay for detecting 24 compounds that affect hESC survival or pluripotency. Our assay was designed to detect changes 
INTRODUCTION

37
The derivation of human embryonic stem cell (hESC) lines opened up exciting opportunities for 38 their use in regenerative medicine, as hESCs can be maintained in culture in an undifferentiated 39 state, while retaining the ability to differentiate into somatic cell types [1] . Delineating the 40 molecular mechanisms that govern hESC self-renewal and differentiation to specific cell types is 41 critical to achieving the potential therapeutic benefits of hESC. Bioactive small molecules have 42 proven to be powerful probes for elucidating mechanisms underlying various cellular processes
43
[2]. Use of small molecules in cell-based phenotype screens provides an unbiased way of 44 dissecting relevant cellular pathways as this approach involves looking for a change in the cell 45 phenotype followed by analysis to identify molecular targets within the cell [3] . and stauprimide, which enhances the directed differentiation of ESCs [5] . Identifying further 50 compounds that can modulate various aspects of hESC biology would be beneficial for 51 improving hESC culture conditions, as well as for controlling differentiation to desired cell types.
52
Yet only a small number of high-throughput (HTS) screens have been performed on hESCs [6, 7] .
53
A further shortcoming has been that as hESC growth characteristics are not readily amenable to 54 HTS set-ups, the published screens required significant adaptation of hESCs to make them 55 compatible with the HTS methodologies used, namely, assessing cells in a monolayer rather than 56 in their normal colony morphology. Such screens would inevitably lose potentially valuable 57 information about changes occurring in cultures after treatment with compounds. 58 4
We have developed a high-content phenotype screen that can detect multiple effects of 66 We developed an image-based high-content assay using the InCell Analyzer (GE Healthcare) 67 automated microscopy system. The assay was designed to measure changes in morphological 68 features of hESC colonies as well as changes in their pluripotency status. To detect changes in 69 hESC pluripotency, we utilized the cell-surface marker TRA-1-60, which is down-regulated upon 70 differentiation [8, 9] . Firstly, we validated our assay using all-trans retinoic acid, a small 71 molecule known to induce differentiation of hESCs [9, 10] . Shef4 hESCs were dissociated to 
DEVELOPMENT OF A HIGH CONTENT ASSAY FOR hESC
77
Data from four fields were acquired from each well using a 4x objective (representing 78 46% of the total well area) for nuclear staining (Hoechst 33342) and TRA-1-60 (FITC) (Fig. 1a,   79 b, c). Automated image analysis software was then used to extract the multivariate data from the 80 acquired colony images. First, fluorescence of the nuclei (Fig. 1b) was used to identify cells in 81 the image, a process known as segmentation, followed by erosion of pixels identified at the edge 82 of each nuclei in the image to minimize overlapping of closely positioned nuclei (Fig. 1d) .
83
Hoechst 33342 also stained nuclei of the feeder cells present. To exclude feeder cells from 84 images, all of the segmented objects in the image were expanded (dilated). This leads to merging 85 of hESC nuclei within a colony as they are positioned closely together. The resulting objects in 86 the image consisted of larger objects representing hESC colonies and smaller objects representing 87 6 dilated feeder cell nuclei (Fig. 1e) . The area of dilated objects and intensity of Hoechst 33342 88 staining (hESC nuclei stain brighter than feeder cells) were used as criteria to reject feeders and 89 leave only segmented hESC colonies in the images for further analysis (Fig. 1f) . To determine 90 the percentage of TRA-1-60-positive hESCs in each field, the segmentation of the individual 91 nuclei (as shown in Fig. 1d ) was used as a mask over the TRA-1-60 image ('nuclear masking', perfectly circular object would have the maximum value of 1) ( Fig. 1i,j) . for the percentage of positive cells in replicate plates was >0.5, indicating our assay was robust.
110
We then applied it to screening a library of small molecules. pyridinyl-N″-(1,2,2-trimethylpropyl)guanidine) [12, 13] (Fig. 2d) .
141
DIFFERENTIATION-INDUCING EFFECTS OF HITS
142
The hits that reduced TRA-1-60 marker expression in the primary screen were mainly 143 corticosteroid drugs, and some of these compounds were structural analogues of one another -144 e.g. prednisolone and 6-alpha methylprednisolone. Apart from reduced TRA-1-60 expression
145
( Fig. 2e) and a reduction in cell numbers (Fig. 2f) , high-content data obtained in our primary 146 screen indicated that steroid treatment gave rise to a distinct morphology of hESC colonies. For 147 example, although the number of colonies was not significantly different from the control (Fig.   148 2g), steroid-treated cells were densely packed into small colonies, and this was reflected in a 149 smaller colony area (Fig. 2h) as well as increased intensity levels of Hoechst 33342 nuclear 150 staining (Fig. 2i) . Furthermore, the steroid hits caused an increase in the form factor of colonies
151
( Fig. 2j) indicating that the Shef4-steroid treated colonies adopted a more circular morphology 152 (Fig. 2k) .
153
We selected four steroid hits from the primary screen, betamethasone, dexamethasone, 154 prednisolone and 6-alpha methylprednisolone, for follow-up analysis. First, we validated the 155 effects of these compounds on the loss of pluripotency using additional markers. Treated hESCs
156
showed a dose-dependant decrease of OCT4 levels ( Fig. 3a and data not shown). We also 9 retained expression of pluripotency markers after 7 days of treatment, indicating that steroid- 
COMPOUNDS THAT INCREASED hESC NUMBERS
167
Amongst the compounds that increased hESC numbers in the primary screen were kinase 168 inhibitors Y-27632, HA1077, HA1004 and H-89, and the potassium channel opener Pinacidil.
169
We analyzed Pinacidil in more detail, as it has not been reported to have effects on hESCs. We Student's t test). Even at the 12.5µM concentration, this effect was still significant (1.95-fold 178 more cells than control, P=4x10 -5 , Student's t test).
179
Given that Pinacidil had a marked effect on cell numbers as early as 2 days after seeding, Pinacidil does not alter the cell proliferation rate (Supplementary Fig. S2d ). Thus, we concluded 208 that Pinacidil is acting as a pro-survival factor of hESCs.
209
The effects of Pinacidil on the pluripotency of hESCs were further examined. FACS 210 analysis of cell surface markers showed continued expression of the pluripotency-associated 211 markers SSEA3 and TRA-1-60, whereas the differentiation-associated marker SSEA1 was 212 reduced in 100µM Pinacidil-treated cells (Fig. 5a) . Quantitative PCR analysis also showed an 213 increase in expression of POU5F1 (OCT4), and NANOG in cells treated with Pinacidil ( Fig. 5b) .
214
To confirm that Pinacidil did not adversely affect the differentiation capacity of hESCs, ABCC9 at the mRNA level (Fig. 6a) . Furthermore, the effect of Pinacidil could not be blocked by 228 using the K ATP channel blocker glibenclamide (Fig. 6b) Pinacidil inhibited PRK2 and ROCK2 activity by more than 90%. Pinacidil also inhibited a 238 number of other kinases (Fig. 6e) .
239
To compare Pinacidil with other survival compounds uncovered in our screen, we tested 240 their effect on hESC growth, using compounds in a range of concentrations from 1 to 100µM.
241
Kinase inhibitors Y-27632, HA1077, HA1004 and H-89 showed the highest effect at 25µM, 242 whereas Pinacidil showed its highest effect at 100µM. Y-27632 was the most potent compound 243 in increasing cell numbers (Fig. 7a) . To determine whether any of the compounds could 244 synergize, each compound was used at its optimal concentration in combination with each of the 245 other compounds. No additive effects were observed (Fig. 7b) . We also tested if kinase inhibitors were used in combinations (Supplementary Fig. S3b ).
250
In the light of the finding that Pinacidil inhibits ROCK2, we compared our kinase activity 251 data obtained for Pinacidil to similar published information available for Y-27632 ROCKi.
252
Pinacidil showed some overlapping targets with Y-27632 (Fig. 7d) Toolbox 1.7 software (GE Healthcare).
387
The Z' factor is a dimensionless parameter used to evaluate the performance of a For growth curve analysis, dissociated Shef4 hESC were plated in 96-well plates on feeders as 403 described above. Cells were fixed with 4% paraformaldehyde at various times after seeding and 404 stained with 10µg/ml Hoechst 33342 (Invitrogen). Plates were imaged using the InCell Analyzer 405 1000 (GE Healthcare) and images were analyzed for number of hESC using Developer Toolbox 406 1.7 software (GE Healthcare) as described above. 
437
Propidium iodide (10µg/ml) (Sigma-Aldrich) was added to each sample followed by analysis of 438 cell fluorescence on a CyAnADP O2 flow cytometer (DakoCytomation, Glostrup, Denmark). Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity,
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